Herrmann T R W, Liatsikos E N, Nagele U, Traxer O, Merseburger A S
Departamento de Urología y Uro-oncología, Medical School of Hanover (MHH), Hanover, Alemania.
Actas Urol Esp. 2013 Feb;37(2):63-78. doi: 10.1016/j.acuro.2012.05.005. Epub 2012 Sep 16.
The European Association of Urology (EAU) Guidelines Office has set up a guideline working panel to analyse the scientific evidence published in the world literature on lasers in urologic practice.
Review the physical background and physiologic and technical aspects of the use of lasers in urology, as well as current clinical results from these new and evolving technologies, together with recommendations for the application of lasers in urology. The primary objective of this structured presentation of the current evidence base in this area is to assist clinicians in making informed choices regarding the use of lasers in their practice.
Structured literature searches using an expert consultant were designed for each section of this document. Searches were carried out in the Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials, and Medline and Embase on the Dialog/DataStar platform. The controlled terminology of the respective databases was used, and both Medical Subject Headings and EMTREE were analysed for relevant entry terms. One Cochrane review was identified.
Depending on the date of publication, the evidence for different laser treatments is heterogeneous. The available evidence allows treatments to be classified as safe alternatives for the treatment of bladder outlet obstruction in different clinical scenarios, such as refractory urinary retention, anticoagulation, and antiplatelet medication. Laser treatment for bladder cancer should only be used in a clinical trial setting or for patients who are not suitable for conventional treatment due to comorbidities or other complications. For the treatment of urinary stones and retrograde endoureterotomy, lasers provide a standard tool to augment the endourologic procedure.
In benign prostatic obstruction (BPO), laser vaporisation, resection, or enucleation are alternative treatment options. The standard treatment for BPO remains transurethral resection of the prostate for small to moderate size prostates and open prostatectomy for large prostates. Laser energy is an optimal treatment method for disintegrating urinary stones. The use of lasers to treat bladder tumours and in laparoscopy remains investigational.
欧洲泌尿外科学会(EAU)指南办公室成立了一个指南工作小组,以分析世界文献中发表的关于激光在泌尿外科实践中的科学证据。
回顾激光在泌尿外科应用的物理背景、生理和技术方面,以及这些新兴技术的当前临床结果,并提出激光在泌尿外科应用的建议。本领域当前证据基础的结构化呈现的主要目的是帮助临床医生在实践中就激光的使用做出明智选择。
针对本文件的每个部分,利用专家顾问进行结构化文献检索。检索在Cochrane系统评价数据库、Cochrane对照试验中心注册库以及Dialog/DataStar平台上的Medline和Embase中进行。使用了各数据库的受控术语,并分析了医学主题词和EMTREE中的相关词条。确定了一篇Cochrane综述。
根据发表日期,不同激光治疗的证据是异质性的。现有证据表明,在不同临床场景下,如难治性尿潴留、抗凝和抗血小板药物治疗中,激光治疗可作为膀胱出口梗阻治疗的安全替代方法。膀胱癌的激光治疗仅应在临床试验环境中使用,或用于因合并症或其他并发症而不适合传统治疗的患者。对于尿路结石治疗和逆行输尿管内切开术,激光提供了一种增强腔内泌尿外科手术的标准工具。
在良性前列腺梗阻(BPO)中,激光汽化、切除或剜除是替代治疗选择。BPO的标准治疗方法对于中小体积前列腺仍为经尿道前列腺切除术,对于大体积前列腺则为开放性前列腺切除术。激光能量是粉碎尿路结石的最佳治疗方法。激光用于治疗膀胱肿瘤和腹腔镜手术仍处于研究阶段。